P2a Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics

Conditions: Ulcerative Colitis Interventions: Biological: ALTB-268 Sponsors: AltruBio Inc. Not yet recruiting

Source: ClinicalTrials.gov - October 31, 2023 Category: Research Source Type: clinical trials